Former filovirus disease names
Filoviruses, the members of the family Filoviridae, are currently classified into one proposed and five estab lished genera (Supplementary Table 1 ). Of the twelve described filoviruses, six have been identified as aeti ological agents of naturally occurring human disease outbreaks.
The International Classification of Diseases (ICD; Supplementary Box 1) is primarily a statistical tabu lation. Consequently, frequently observed diseases with large patient cohorts are more likely to have their own disease names, codes and subcategories of disease manifestations than uncommonly occurring diseases because larger cohorts ensure statistical reliability of disease descriptions. Given the past low number of filovirus disease outbreaks and overall case numbers (34 disease outbreaks until 2 013, involving 2,872 cases and 1,968 deaths), it is not surprising that the diseases caused by filoviruses were not captured by early ICD iterations. In ICD9, the only code defining filovirus diseases was '078.89 Other specified diseases due to viruses' . Consequently, various unofficial filovirus dis ease names have been used in the scientific literature (Supplementary Tables 2,3 ).
The currently used ICD10 recognizes filovirus dis eases specifically via entries ' A98.4 Ebola virus disease (EVD)' and ' A98.3 Marburg virus disease (MVD)' since 1994. However, ICD10 does not specify which filovi ruses are considered to cause which of the two diseases, offer disease definitions or account for unusual disease manifestations (for example, subclinical or persistent infections).
A need for new filovirus disease names
In 2014, Ebola virus (EBOV) was identified as the aetio logical agent of an EVD outbreak in Western Africa that, from 2013 to 2016, caused at least 28,652 human infec tions and 11,325 deaths. This single outbreak involved almost ten times the combined number of patients from all previous filovirus disease outbreaks. Consequently, the clinical presentation of EVD could be refined using statistical measures, and subclinical EBOV infections leading to sexual transmission or disease relapse were substantiated through clinical observations. In addi tion, often debilitating sequelae in EVD survivors were observed longitudinally for the first time using large cohorts. As clinical research data on EVD accumulated, the coverage of filovirus disease in ICD10 was inade quate to cover complex clinical presentations of filovirus disease.
Discussion framework
Expert panel and method. Responding to the WHO's public call for input in the development of ICD11, we assembled a large group of experts (the authors) who treated filovirus infected patients or were heav ily involved in organizing the treatment of patients to develop ICD11's entries on filovirus disease. Consensus was obtained by step wise, simple majority, semi blind voting. The participants represented a wide spectrum of scientists and health workers of both sexes and from numerous countries, including African nations most affected by human filovirus infections.
Main issues. ICD10 recognizes two filoviruses dis eases: EVD and MVD; however, four ebolaviruses (members of the genus Ebolavirus) cause disease, with EBOV only being one of them, and two marburgvi ruses (members of the genus Marburgvirus) cause disease, with Marburg virus (MARV) being one of them. The terms 'Ebola virus disease' and 'Marburg virus disease' are therefore ambiguous: either ICD10 does not capture diseases caused by ebolaviruses and marburgviruses other than EBOV and MARV or EVD and MVD are cover terms for diseases caused by all ebolaviruses and marburgviruses (MARV and Ravn virus (RAVV)), requiring authors to specify which ebolavirus or marburgvirus caused a particular EVD or MVD outbreak. These ambiguities cause major confusion in communication among researchers and copy editors who are not necessarily familiar with the differences between 'Ebola virus' and 'ebolavirus' or
New filovirus disease classification and nomenclature
The recent large outbreak of Ebola virus disease (EVD) in Western Africa resulted in greatly increased accumulation of human genotypic, phenotypic and clinical data, and improved our understanding of the spectrum of clinical manifestations. As a result, the WHO disease classification of EVD underwent major revision. 'Ebola virus disease due to Ebola virus infection' versus 'Ebola virus disease due to Bundibugyo virus infection'
1 . Consequently, the expert panel debated whether the EVD and MVD entries in ICD10 should be merged into a single entry, whether the two terms should be split into several entries based on aetiologi cal agents or whether a hierarchical scheme should be adopted to cover both possibilities.
Official virus taxonomy may change annually through decisions made by the International Committee on Taxonomy of Viruses (ICTV), but ICD updates and revisions are released at much longer intervals. Hence, the ICD cannot keep pace with taxonomic develop ments. Independence of ICD11 filovirus disease names from virus taxonomy considerations was therefore thought to be imperative.
Results of expert panel discussions
A single umbrella term for the diseases caused by filoviruses is urgently needed, as differentiation between ICD10's EVD and MVD on clinical grounds alone is impossible. Following the publication of the 'WHO Best Practices for the Naming of New Human Infectious Diseases' , this parent disease name should not contain any geographical locations; people's names; species or class of animal or food; cultural, popula tion, industry or occupational references; or compo nents that incite undue fear 2, 3 . Furthermore, the panel almost unanimously discouraged the use of 'haemor rhagic fever' for any filovirus associated disease name because 'haemorrhagic fever' is not unambiguously defined, and the majority of filovirus infected individ uals do not develop overt haemorrhage. Consequently, health care workers could misdiagnose filovirus dis eases, or potentially infected individuals may not seek admittance to a treatment unit based on the absence of haemorrhage. After thorough consideration, 'Filovirus disease (FVD)' was chosen as the ICD11 parent dis ease term. Because filoviruses comprise a distinct and monophyletic group of viruses, the expert panel felt that the prefix 'filo' was unlikely to disappear in the near future if taxonomic changes to the virus family would be required. Additional subcategories should be established to codify diseases caused by filovirus that
have not yet been associated with filovirus disease or yet tobe discovered novel filoviruses, diseases very likely caused by filoviruses without final agent confir mation, and filovirus diseases with 'unusual' clinical presentations.
The panel advocated for two subcategories to the filovirus parent entry for ebolavirus and marburgvirus diseases and recommended, if necessary, further subcat egorization. The classical distinction of ICD10's EVD and MVD was felt to be important for traditional and familiarity reasons. Furthermore, molecular evidence is accumulating that ebolaviruses and marburgviruses behave differently in vitro and in vivo, suggesting that differences in clinical presentation of infections with ebolaviruses or marburgviruses will become evident in the future. 'Ebola disease (EBOD)' and 'Marburg dis ease (MARD)' were chosen for the major FVD subcate gories (Box 1): FVD due to ebolavirus and marburgvirus infections, respectively. The WHO naming guidelines were not applied in coining these terms because both 'Ebola' and 'Marburg' have been components of filovi rus disease names since the 1970s and 1960s, respec tively. The absence of the word 'virus' in the two disease names makes them taxonomically independent and therefore stable.
The panel then reintroduced the ICD10 names 'Ebola virus disease (EVD)' and 'Marburg virus disease (MVD)' as EBOD and MARD subcategories because of their familiarity to the filovirus research community but restricted the use of EVD and MVD to diseases caused by agents belonging to only one species: EBOV (species Zaire ebolavirus), and MARV and RAVV (both species Marburg marburgvirus), respectively. Two additional EBOD subcategory disease terms were added to cover the remaining pathogenic filoviruses that have caused more than one registered human infection: Bundibugyo virus disease (BVD) and Sudan virus disease (SVD). Three additional subcategories for both EBOD and MARD were proposed: ' Atypical Ebola/Marburg disease' for EBOD or MARD patients with unusual clinical presen tations; 'Other specified Ebola/Marburg disease' for EBOD or MARD patients infected with ebolaviruses or marburgviruses not covered by BDV, EVD and SVD or MVD (for example, disease due to Taï Forest virus infection); and 'Ebola/Marburg disease, virus unspeci fied' for patients who are suspected to be infected with an ebolavirus or marburgvirus in absence of virus identification.
The expert panel did not establish a separate category for filovirus induced sequelae in filovirus disease sur vivors (for example, 'post Ebola syndrome') as ICD11 allows combinatorial coding (for example, ' Atypical Ebola disease' plus ' Arthritis').
New official filovirus disease names
The panel submitted a proposal containing the pro posed filovirus disease classification and nomencla ture to the WHO's ICD11 Proposal Platform in April 2018. After peer review and appropriate revisions, the new filovirus disease classification and nomencla ture (Box 1; Supplementary ICD11 framework. The panel recommends that the new filovirus disease names and abbreviations be used immediately in forthcoming filovirus publications to ensure a seamless transition once ICD11 is adopted by United Nations member states.
